I’ve had two conversations in the last few months about the future of synthetic drugs. Both conversations were with respected politicians (one elected, one a candidate), and both followed the lines of a similar narrative that goes a little something like this: synthetic drugs are cheaper and easier to manufacture than their natural forebears. The receptivity to these drugs is rising due to a variety of socioeconomic factors. There is a worrying deterioration of physical and mental health in...
